A national forum, led by the Global Liver Institute, has begun mapping new pathways to diagnose Metabolic Associated Steatohepatitis (MASH) earlier. By focusing on non-invasive liver screenings and identifying high-risk groups sooner, the initiative aims to reshape the approach to liver health and save countless lives.